Ryan Savitz, EVP, CFO & Cbo: Dianthus Therapeutics DNTH Sell · Filed 04/10

Trade details

Type: Insider sale
Amount: $738,844.16
Shares · price: 8,224 sh · $89.84 a share
Held after: 0 sh
Stock: Dianthus Therapeutics DNTH
Person: Ryan SavitzEVP, CFO & Cbo
Trade date: 26/04/09
Filed: 26/04/10
Days to filing: 1 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Dianthus Therapeutics trades, last 26 weeks

What else happened in Dianthus Therapeutics around then

Filed or reported within 30 days of the trade day · 03/10~05/09

Ryan Savitz's recent trades

Ryan SavitzEVP, CFO & Cbo
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$3.1M
31,249 sh
$3.1M
Filed 07/09
Traded 07/09
Ryan SavitzEVP, CFO & Cbo
Planned sale10b5-1 planDianthus Therapeutics
Planned sale10b5-1 plan
Dianthus Therapeutics
DNTH
$719.4K
8,224 sh
$719.4K
Filed 04/09
Traded 04/09
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$5M
59,800 sh
$5M
Filed 04/01
Traded 03/31
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.7M
21,825 sh
$1.7M
Filed 04/01
Traded 03/31
Ryan SavitzEVP, CFO & Cbo
Sell10b5-1 planDianthus Therapeutics
Sell10b5-1 plan
Dianthus Therapeutics
DNTH
$1.6M
19,469 sh
$1.6M
Filed 04/01
Traded 03/31